SEC Form 4 · purchase transaction · filed Oct 9, 2026
Epstein David R purchased $44.5K of AgomAb Therapeutics NV
Epstein David R (Director) disclosed a purchase of 5,000 shares of AgomAb Therapeutics NV (AGMB) at $8.90 per share on Oct 8, 2026, in a Form 4 filed with the SEC on Oct 9, 2026. Disclosed value $44.5K. 3 distinct insiders disclosed purchases of AgomAb Therapeutics NV in the 7 days to Oct 9, 2026, within Flock's Form 4 coverage.
The filing, as filed
| Reporting insider | Epstein David R |
|---|---|
| Role as filed | Director |
| Company | AgomAb Therapeutics NV (AGMB) |
| Security as filed | Common shares |
| Transaction | Purchase (Form 4 transaction code P: open-market or private purchase) |
| Shares | 5,000 |
| Price per share | $8.90 |
| Disclosed value | $44,500.00 ($44.5K; quantity × the filing's stated price) |
| Trade date | Oct 8, 2026 |
| Filed with the SEC | Oct 9, 2026 |
Source: SEC EDGAR Form 4. Purchase transactions only (code P) — grants, option exercises and tax withholdings are different facts and are never shown as buys. Superseded filings are excluded. Coverage: the US issuers in Flock's Form 4 scope (securities mapped from institutional 13F holdings), not every SEC registrant.
Disclosures shown are public regulatory filings. Data may be delayed or incomplete. Smart-money entities may no longer hold positions shown. Not investment advice.
Related on Flock
The Smart Money Digest
A free weekly email of notable disclosure activity — every line with its filing date and source link. No advice, just filings. Unsubscribe anytime.